2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$4.76-$0.02 (-0.44%)
Price as of Sep 11, 2026 7:39 PM EDT- $599.9MMarket Cap
- -5.35%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$4.76-$0.02 (-0.44%)
AQST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.78 | ||
Change | -$0.21 (-4.21%) | ||
Open | $4.99 | ||
High | $5.13 | ||
Low | $4.74 | ||
Previous Close | $4.99 | ||
Volume | 4,159,293 | ||
30-Day Average Volume | 3,460,577 | ||
1-Week Change | -10.49% | ||
1-Month Change | 8.39% | ||
1-Year Change | -5.35% | ||
3-Year Change | 204.46% | ||
5-Year Change | 7.90% | ||
Fundamentals | |||
Shares Outstanding | 125.5M | ||
Total Assets | $132.1M | ||
Market Cap | $599.9M | ||
Enterprise Value | $552.1M | ||
Period: QTR TTM FY | |||
Revenue | $13.8M | ||
Net Income | -$22.9M | ||
Free Cash Flow | -$9.7M | ||
EBIT | -$22.9M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $102.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 40 | ||
P/B | -11 | ||
P/E | -27 | ||
PEG | 0 | ||
Price/Free Cash Flow | -62 | ||
Price/Operating Cash Flow | -64 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue